Certified Drug Regulatory Affairs Professional Certification Exam

Certified Drug Regulatory Affairs Professional FDA approval pathways split into distinct tracks—505(b)(1) for novel drugs, 505(b)(2) for generic variations—and this exam drills into how pharmaceutical companies navigate each. You’ll dissect CTD dossier organization, pharmacovigilance reporting timelines, and international regulatory harmonization under ICH guidelines. Real-world submission strategy matters as much as theoretical compliance frameworks here.